Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘antibodies’

February 16, 2021

Mayo Clinic Research in the news — 2/15/2021

By Advancing the Science contributor Advancing the Science contributor

Mayo Clinic research and faculty were highlighted in a range of articles over the last week. Headlines and links below to stories on research collaborations and expansions, as well as specific disease advancements, and all the latest COVID-19 news and information.  Ionic liquid formulation can uniformly deliver chemotherapy to tumors while destroying cancerous tissue in […]

View full entry

Tags: aging, Alzheimer's disease, antibodies, cancer, CAR-T, COVID-19, diabetes, gastrointestinal cancer, heart failure, hereditary diseases, News of the Week, opioids


December 21, 2020

Mayo Clinic Research in the news — 12/21/2020

By Elizabeth Zimmermann Elizabeth Zimmermann

Mid-December, many people are focused on activities and information related to the holidays. The news media are no exception, with very little attention paid to health care research, unless it has a holiday hook. As a result, news is slim about various advancements in understanding, treating and preventing disease. Nonetheless, Mayo Clinic Research and researchers […]

View full entry

Tags: ADHD, antibodies, artificial intelligence, Barrett's esophagus, Brian Lacy, cancer, cardiovascular disease, clinical trials, COVID-19, data science, epidemiology, esophageal cancer


November 23, 2020

Mayo Clinic Research in the news — 11/23/2020

By Elizabeth Zimmermann Elizabeth Zimmermann

There were all sorts of different things in the news this week, but perhaps the most heartening was the news from Dr. Anthony Fauci and our own Gregory Poland, M.D., that Santa Claus and the elves are practicing safe behaviors and COVID-19 won’t stop Christmas from arriving.  Read on for excerpts from this and other […]

View full entry

Tags: Amir Lerman, Andrew Badley, Anna Subramaniam, antibiotic, antibodies, anxiety, autism, cardiovascular medicine, clinical research, COVID-19, depression, DNA


October 15, 2020

The latest on testicular cancer-associated KLHL11 encephalitis

By Advancing the Science contributor Advancing the Science contributor

Divyanshu (Div) Dubey, M.B.B.S., a Mayo Clinic physician and researcher, who holds a dual appointment in neurology, and laboratory medicine and pathology, recently led a multi-institutional research study to advance understanding of KLHL11 encephalitis or testicular cancer-associated paraneoplastic encephalitis. Published in JAMA Neurology, the paper builds on the work Dr. Dubey and other members of […]

View full entry

Tags: antibodies, brain, collaboration, Department of Laboratory Medicine and Pathology, Divyanshu Dubey, DNA, encephalitis, neurology, testicular cancer


October 9, 2020

Mayo Clinic Research in the news — 10/9/2020

By Elizabeth Zimmermann Elizabeth Zimmermann

While Mayo Clinic has long been known as a clinical powerhouse, only more recently has the world actively noted our Research and Education shields. This increased awareness has led to visibility for both our research and our researchers in national and international news and education forums. In the past week, they have been featured in […]

View full entry

Tags: Alzheimer's disease, amnesia, antibodies, Barry Borlaug, biomarkers, biostatistics, blood pressure, Bobbi Pritt, clinical trials, Colin West, community engagement, Cornelius Thiels


September 16, 2020

Mayo Clinic research advances diagnostics to lead COVID-19 pandemic response

By Susan Murphy Susan Murphy

When COVID-19 spread across the U.S. in early March, Mayo Clinic’s Advanced Diagnostic Laboratory (ADL) urgently responded. Lab spaces were transitioned, staff reassigned and funding approvals were fast-tracked. Its goals were to accelerate research, development, translation and implementation of novel tests in order to discover life-saving treatments and diagnostics. “ADL houses a lab structure for […]

View full entry

Tags: Ann Moyer, antibodies, Benjamin Kipp, Bobbie Pritt, Center for Individualized Medicine, COVID-19, Department of Laboratory Medicine and Pathology, Dietrich Matern, Elitza Theel, genetics, genomics, John Mills


August 14, 2020

Mayo Clinic Research in the news 8/14/2020

By Elizabeth Zimmermann Elizabeth Zimmermann

While much of the news around health care research is COVID-19 related, Mayo Clinic researchers are hard at work across the entire spectrum of health and health care delivery. Our multidisciplinary research teams are seeking ways to improve outcomes, lower costs and enhance the experience of patients, providers and caregivers. Read on for snippets of […]

View full entry

Tags: aging, Andrew Badley, antibodies, breast cancer, chemotherapy, Clifford Jack Jr., clinical research, clinical trials, COVID-19, Devon Rubin, Eugenia Trushina, Grzegorz Nowakowski


August 7, 2020

Research News Roundup — July 2020

By Elizabeth Zimmermann Elizabeth Zimmermann

It sometimes seems that summer has flown by without any significant achievements, and only incremental evidence building in the topic of the moment. COVID-19 has had a major dampening effect on social interaction, one doesn’t need to be a researcher to figure that out. However, biomedical and health care delivery research have not paused for […]

View full entry

Tags: antibodies, bacteriophages, basic science, blood clots, CAR-T, COVID-19, discovery research, immunity, non-Hodgkin lymphoma, phage, prosthesis, Research News Roundup


June 2, 2020

Research News Roundup — May 2020

By Elizabeth Zimmermann Elizabeth Zimmermann

During May, Mayo Clinic articles sharing research-related news fell into one of two thematic areas: cancer and COVID-19. For ease of review, they are grouped below, cancer findings first. Read on for more information from Mayo Clinic Research. Cancer research findings Carfilzomib is not superior to Bortezomib in delaying multiple myeloma progression after initial treatment Carfilzomib, a […]

View full entry

Tags: antibodies, artificial intelligence, cardiovascular medicine, Center for Clinical and Translational Science, Charles Loprinzi, chemotherapy, community engagement, COVID-19, gastroenterology, health disparities, Mayo Clinic Cancer Center, Mayo Clinic Laboratories


May 18, 2020

Mayo Clinic Research in the News — Week in Review 5/18/2020

By Elizabeth Zimmermann Elizabeth Zimmermann

Mayo Clinic researchers continue to share both their expertise and their research findings in regional, national and international news. Collected here are links and snippets from some of the stories from around the world. They connect Mayo Clinic research and international efforts to understand and reduce the devastating effects of the SARS-CoV-2 virus and COVID-19. Mayo […]

View full entry

Tags: antibacterial resistance, antibodies, artificial intelligence, cardiology, cardiovascular medicine, clinical trials, COVID-19, Gianrico Farrugia, heart failure, infectious disease, Joseph Poterucha, Mayo Clinic Health System


Contact Us · Privacy Policy